# Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes

> **NCT00308308** · PHASE3 · COMPLETED · sponsor: **Mannkind Corporation** · enrollment: 589 (actual)

## Conditions studied

- Diabetes, Type I

## Interventions

- **DRUG:** Technosphere Insulin
- **DRUG:** Active comparator

## Key facts

- **NCT ID:** NCT00308308
- **Lead sponsor:** Mannkind Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2008-07
- **Final completion:** 2008-08
- **Target enrollment:** 589 (ACTUAL)
- **Last updated:** 2014-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00308308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00308308, "Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00308308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*